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1. Introduction  
Diabetes Mellitus is a growing health problem worldwide and will reach epidemic 
proportions in the next years. Chronic complications of diabetes cause an important rate of 
morbidity, from ischemic heart attacks to lower extremity amputation. The total number of 
excess deaths attributable to diabetes worldwide for the year 2010 was estimates in 3.96 
million for the age group 20-79 years-old. This represents 6.8% of the global mortality for all 
ages. (Gojka and Unwinb, 2010) 
A tight glycemic control and a close monitoring of all cardiovascular risk factors is essential 
to prevent serious complications of diabetes and to reduce mortality. Health care systems 
need to look for new approaches to afford the overload of diabetic patients and to provide 
them with an effective and cost-effective assistance.  
Telemedicine-based systems for sharing information between patient and health 
professional may facilitate the high level of assistance required by diabetes.  
Transmission of capillary blood glucose values by the patient and a regular feedback from 
the professional are the basis for patient education in the self-management of their disease. 
The exchanged information could be much more complex, including data on food intake, 
level of exercise, dose of insulin…Taking into account all these parameters, health 
professionals may adjust the therapy in a more accurate way. Certain groups of patients 
may benefit more due to their special care needs: type 1 diabetes, patient treated with a 
continuous insulin infusion system, pregnant woman with diabetes, among other situations. 
All of them require close monitoring. Telemedicine may help to reconcile the care process 
with patient's lifestyle.  
However, the real presence of Telemedicine in clinical practice is still very limited in most 
centres attending diabetic patients. Many studies have been performed in the last years in 
order to evaluate different Telemedicine approaches to diabetes care. Most of these studies 
involve a small number of patients and can be just regarded as pilot experiences. The 
heterogeneity among the evaluated systems makes difficult to provide strong conclusions 
about the effectiveness of Telemedicine in the control of the diabetic patients. Wider 
research in this area is required in order to create a more reliable perception about these 
systems among patients and health professionals.  
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Our group from the Endocrinology and Nutrition Department of Hospital Clinico San 
Carlos (Madrid, Spain) carried out a clinical trial in the year 2007 to evaluate the feasibility 
of a Telemedicine system based on Internet and short message service in the follow-up of 
women with gestational diabetes. 100 women were followed during their third trimester of 
pregnancy, 50 of them using Telemedicine. This experience provided a useful view of the 
possibilities of these systems, but also of the difficulties and how to improve them for the 
application in clinical practice.  
On the other hand, Telemedicine has been applied successfully in the diagnosis and 
management of chronic complications of diabetes such as diabetic retinopathy. The 
transmission of digital images of the retina to specialized centres where they are properly 
interpreted may increase the access to specialized care, improve the screening of diabetic 
retinopathy and make possible an early treatment.  
A screening protocol of diabetic retinopathy using Telemedicine has been developed in 
Hospital Clinico San Carlos from the year 2008.  The programme has shown to be effective 
in selecting the patients that must be evaluated by ophthalmologists with more experience 
in the management of retinopathy. This implies an optimization of resources and an 
improvement in patient satisfaction. 
The application of Telemedicine in the follow-up of other chronic complications of diabetes 
is also a very interesting area of research: the evaluation of foot ulcers through digital 
images that could be transmitted to experts, the monitoring of patients with cardiovascular 
disease, and many other applications that we will see in the next years. Therefore, 
Telemedicine represents an amazing advance in the care process of the diabetic patient. 
2. Definition of telemedicine  
Telemedicine covers a wide variety of procedures with very different stages of complexity. 
From a simple telephone conversation between two health professionals sharing 
information, to complex diagnostic or therapeutic procedures long distance and in real time.  
Telemedicine is a technological tool that enables the optimization of health care services, 
allows saving time and resources and facilitates access to remote areas in order to provide 
them with specialist care.  
It enables the exchange of information between different health professionals, including 
primary care physicians and specialists, or between professional and patient. This latter 
form is known as Telecare, which aims to improve the quality of care through an increased 
communication between the patient and the healthcare professional. In this process there is 
a unit of the patient and a health professional station. The shared information may include 
electronic documents, digital images and any data of interest in patient monitoring.  
The amazing advances in the area of information technology and communication in last 
decades has allowed the development of multiple approaches to Telemedicine. 
Communication tools used so far are very diverse: fixed telephony, modem, mobile phone 
short text messages (SMS), Internet e-mail, Web application, video-conference, GPRS 
technology, Bluetooth, Integration Computer Telephony, and Multi-Access Systems: Web 
application, dial through interactive voice response, palms (PDAs)... The available systems 
are becoming more diverse and higher quality through constant innovation in this field, but 
they are also more reasonable in cost. 
The field of information technology and telecommunications has started offering to health 
professionals new Telemedicine systems to facilitate their daily work. However, there is still 
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a lack of knowledge about the possibilities of these systems and, occasionally, some 
resistance of health authorities for the implementation of Telemedicine in clinical practice.  
The European Commission launched in 2009 a consensus document to encourage member 
states in the effort to integrate these new services in health systems. The actions proposed to 
undertake in the next three years are aimed at the following points:  
- Improve the confidence and acceptance of Telemedicine systems by conducting large-
scale studies of effectiveness and cost-effectiveness. 
- Build a stable legal framework, with the adaptation of the regulations of each country.  
- Solve technical problems and facilitate market development, promoting interoperability 
and improve their quality and safety.  
3. Telemedicine applications in diabetes: why to apply telemedicine in 
diabetes care? 
Telemedicine has been applied in the follow-up of chronic diseases such as hypertension, 
obesity, chronic obstructive pulmonary disease, asthma, even in the monitoring of oncology 
patients. But no doubt Diabetes is the chronic disease with more approaches using 
Telemedicine. This is due to the special characteristics of the monitoring and treatment of 
this disease.  
Multiple evidences show that complications of diabetes can be prevented by a tight 
metabolic control and an adequate monitoring of the patient. However, to achieve this 
control is essential a close relationship between the practitioner and the patient, which 
should be consistent and prolonged in time. As an example, patients from the intensive 
group in the DCCT study visited the medical centre every week until reaching the target, 
then every month, and received weekly telephone contact to adjust the treatment. (DCCT 
Research Group, 1989). This level of support is difficult to implement in clinical practice 
because of the increasing prevalence of diabetes and the incompatibility with the patient's 
lifestyle (work or school activity). 
The level of involvement required from the diabetic patient in the control of his own disease 
is higher than in any other disease. That’s why such close contact with the health 
professional is necessary. The patient with diabetes should self-monitor his capillary blood 
glucose, as directed by the health team (nurse educator and doctor). There must be a 
constant feedback to adjust their treatment according to these values of blood glucose.  
This communication is also essential to evaluate and modify if necessary dietary habits and 
instructing patients on the interpretation of their blood glucose levels in relation to nutrition 
and physical activity. The patient must be always guided by the health professional in order 
to gradually learn to make decisions about his own treatment.  
This requires, in all its developments but more importantly in the early stages of diagnosis 
and at specific situations, constant and close supervision by medical staff, an individualized 
treatment and continuous education.  
In other cases, the metabolic control is affected by the motivation of the patient over time. In 
many cases a positive encouragement is needed to implement the self-management of 
diabetes, for example in certain life stages such as adolescence.  
Therefore, professionals look for new solutions in order to facilitate the contact with the 
patient, to create a more dynamic and motivating communication and that may be 
compatible with the patient's lifestyle.  
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4. Review of the literature: what has been done by other researchers? 
In the early 80s, Telemedicine systems started to be implemented in monitoring the diabetic 
patient and, since then, many approaches have been developed following the quick 
evolution of information technology and communication in the last 30 years.  
The first systems allowed the transmission of blood glucose values from the patient to the 
healthcare professional by fixed telephone or modem. The practitioner replied to the patient 
by telephone and gave him recommendations for treatment. Using this system in type 1 
diabetic patients, the study of Chase et al. (Chase et al., 2003) showed that modem 
technology can be useful and cost-effective in the process of patient care. 70 patients were 
followed for 6 months. The control group performed visits every three months, while the 
intervention group sent their blood glucose data by modem every two weeks, receiving a 
"feedback" via telephone by the professional. At the end of the follow-up, there were no 
significant differences in HbA1c value or number of severe hypoglycemia. However, the use 
of telemedicine system was more cost-effective and reduced the number of school and work 
absences during the follow-up.  
A subsequent meta-analysis (Montori et al., 2004), including controlled clinical trials using 
only the modem transmission of glucose data from the glucometer of type 1 diabetic 
patients, found a difference of 0.4% (95% CI 0 to 0.8) in mean change in HbA1c from 
baseline between intervention and control group. They were paediatric patients, type 1 
diabetics with poor glycemic control and women with pregestational diabetes. However, the 
follow-up time was short (average 6 months), and a small number of patients (average of 50 
patients), so can not assess long-term feasibility.  
Internet development was a breakthrough in the field of Telemedicine. In the following 
studies, the patient is able to communicate with the healthcare professional via the Internet, 
existing Web-based applications. The patient access the application from home or from a 
pocket computer, sending their values of blood glucose, and other data necessary for the 
interpretation of blood glucose levels as the dose of medication, diet and physical activity 
level. The health professional receive this information in the medical station (usually a PC) 
and replies with individualized recommendations, which are received via the Internet in the 
terminal of the patient (Kwon et al., 2004).  
In other studies, the communication by telephone or by text message service is used as a 
complement of Internet communication. (Kwon et al., 2004; Tasker et al., 2007). More recent 
studies integrate several forms of telemedicine, as in the M2DM project developed by the 
European Commission in different centres in Europe (Bellazzi et al., 2003; Bellazzi et al., 
2004), which uses a multi-access system consisting of a Web application, dial through 
interactive voice response, palms and intelligent modems. This project aims to assess 
clinical, organizational, economic and patient satisfaction, with encouraging results.  
Some studies tested educative modules associated with the Web application as a source of 
information and patient training on basic concepts and skills for managing their diabetes 
(McMahon et al., 2005). The ability to access to these educational resources has been shown 
to improve patient motivation, which has a positive influence in their glycemic control.  
Available studies of telematics systems applied to diabetes are generally short in follow-up 
and small in sample sizes. To date, the study that has evaluated over a longest time the 
usefulness of a glucose monitoring system based on Internet, had a follow-up of 30 months 
(Cho et al., 2006). It concluded with a significantly greater reduction in HbA1c and a 
reduction in the rate of fluctuation of HbA1c in the intervention group compared to control. 
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Patients in the intervention group with baseline HbA1c ≥ 7% had HA1c levels markedly 
lower than the corresponding control group patients during the first 3 months (7.9 ± 1.0 vs. 
7.3 ± 0.7, p = 0.023 ) and levels remained stable throughout the study (HbA 1c fluctuation 
index of 0.47 ± 0.23 vs. 0.78 ± 0.51, p = 0.001).  
The development of decision support systems in the last years offers another very 
interesting field in Telemedicine. These systems can help the practitioner in making 
decisions about the management of their patients, by identifying problems and suggestions 
of treatment modifications in diet or physical activity levels, based on intelligent algorithms. 
In a Korean study (Kim et al., 2007), patients sent their data of blood glucose recorded in the 
glucometer, exercise data recorded on a pedometer and a food diary. Data were processed 
in a "matrix of knowledge" that generated automatically by an intelligent algorithm 
messages with recommendations and positive reinforcement directed to patients. After a 
follow-up of 12 weeks, a significantly greater reduction in HbA1c was achieved in the 
intervention group compared to controls (0.72 ± 0.80 vs. 0.15 ± 0.85%, p = 0.005). These 
results could be explained simply because the patients in the intervention group received 
more frequent recommendations based on current data compared with the control group, 
which encourages patients to more actively modify their lifestyle to achieve better glycemic 
control. 
One meta-analysis (Verhoeven et al., 2007) reviewed 39 clinical studies (1994-2006), of which 
22 used Telecare, 13 video and 4 combined Telecare and video conferencing. Telecare 
systems, involving monitoring of clinical, education and personalized feedback were most 
effective in achieving change in habits and reducing costs. They conclude that they are all 
practical, cost-effective and safe in the diabetes care system. However, the heterogeneity in 
study designs and results make difficult to give definitive conclusions about the benefits of 
telemedicine in the management of diabetes. 
Thus, well designed clinical trials are needed to provide consistent evidence on the 
usefulness of Telemedicine systems, so that they can gradually overcome the barriers to its 
implementation in clinical practice. 
5. Telemedicine applications in gestational diabetes 
The patient with gestational diabetes requires a careful monitoring for a short period of 
time, from the diagnosis of gestational diabetes to the moment of delivery. Tight glycemic 
control in gestational diabetes is critical in reducing perinatal morbidity and mortality and 
avoiding maternal complications. During that short period of time, the patient should adopt 
nutritional and physical activity recommendations, must self-monitor her capillary blood 
glucose frequently, and in some cases must start using insulin. It therefore requires close 
monitoring and frequent visits to the medical centre.  
The prevalence of GDM in Spain is increasing in the last years, especially in the immigrant 
population. It means an overload of care, so new strategies for their attention are needed. 
So far there are few studies published that specifically evaluates a telemedicine system in 
the management of gestational diabetes. In one of these studies was provided Internet 
access to women of low economic level to communicate with health professionals. There 
were no significant differences in the values of pre-and postprandial blood glucose, but 
more patients from the intervention group were treated with insulin (31% vs. 4%, p <0.05). 
The system showed no improvement in maternal and fetal parameters, although women in 
the telemedicine group reported greater satisfaction with their diabetes control.  
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6. Experience in Hospital Clinico San Carlos:  
A Telemedicine system based on Internet and short message system as a new approach in 
the follow-up of gestational diabetes mellitus. Es-Te-Dia Project. (Pérez-Ferre et al., 2010; 
Pérez-Ferre et al., 2010) 
In order to test the feasibility of a Telemedicine system in the follow-up of gestational 
diabetes, a pilot study was conducted at Hospital Clínico San Carlos.  
6.1 Subjects, materials and methods  
Patients.  
A prospective randomized interventional study with two parallel groups was designed. All 
women diagnosed as having gestational diabetes (GDM) according to Carpenter-Coustan 
criteria before 28 weeks of gestation and referred to the Unit of Gestational Diabetes of San 
Carlos University Hospital (HCSC) from June to December 2007 were invited to participate 
in the study. Women with inability to understand or to comply with the protocol were 
excluded.  
100 women signed written informed consent and were randomized by age and obstetric 
history, allocated to an intervention group (A, n = 50), provided with a Telemedicine system 
detailed below, and a control group (B, n = 50) that was followed in accordance with the 
usual monitoring face-to-face based protocol in HCSC.  Patients were followed until the 
delivery. 97 women completed the study (48 from group A and 49 from group B, 
respectively).  
Experimental design  
At visit 0 (between 24-28 weeks of pregnancy), patient data were collected: age, nationality, 
educational level, employment status, problems to access the medical centre, family history, 
personal history (hypertension, smoking habit, obesity, thyroidal disease, other co 
morbidities), obstetric history (number of pregnancies, abortions, gestational diabetes in 
previous pregnancies), use of medications, body weight and height.  
Patients were instructed by the nurse educator as regards to nutritional habits and self-
monitoring of capillary blood glucose, and informed about the goals of glycemic control: 
fasting and pre-prandial blood glucose <95mg / dl, and 1-hour postprandial blood glucose 
<120mg / dl.  Body weight, blood pressure, HbA1c and first morning urine sample 
albumine-to-creatinine ratio were assessed. 
At visit 1, one week later (before 28 weeks gestation), capillary blood glucose values were 
evaluated. Six capillary blood glucose determinations a day were recommended during the 
first week. If more than 4 of 5 fasting and pre-meal glycemic values were <95mg/dl in the 
first week, only 1 hour post-meals capillary blood glucose determinations daily or each 
other day were recommended until delivery.  
Patients were randomized in two groups (control and intervention), according to age and 
obstetric history. However, those patients most likely to require insulin after the evaluation 
of the first 7-days blood glucose profiles (at least 50% of post-meals blood glucose 
values>115mg / dl) were allocated to the Telemedicine group, because this subgroup of 
patients was expected to need more provider contacts and could benefit more from the 
Telemedicine system.  
During the follow-up of both groups, 4 face-to-face visits were scheduled until delivery 
(before 28 weeks of gestation, and between 32-34, 36-38, 39-40 weeks).  Body weight, blood 
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pressure, HbA1c and first morning urine sample albumine-to-creatinine ratio were 
determined in every visit. Capillary glucose values recorded by the patient in her log-book 
were evaluated, and episodes of mild or severe hypoglycaemia and insulin requirements 
were collected.  
Patients in the control group (B) were followed according to the usual protocol for 
gestational diabetes at HCSC, including the same capillary blood glucose targets, in a way 
that gave them the opportunity to attend to the medical centre without prior appointment 
(non-scheduled visit) to show their log-book when their blood glucose values were above 
the objectives or for any queries regarding nutritional recommendations or insulin dose. The 
total number of non-scheduled visits to the medical centre, number of work absences and 
number of hospital admissions were regularly recorded.  
Telemedicine System  
The Telemedicine system consists of a central database and peripheral units, consisting of 
cellular phones and a Glucometer capable of transmission via infrared port.  
The intervention group received a Glucometer (Accu-Chek Compact Plus) with a cellular 
phone (Nokia E50-1). The cellular phone has a preinstalled application that allows the 
transmission of capillary glucose values to the central database through short message 
service (SMS). This application has also an interface that allows the infrared transmission of 
the glucose values stored in the glucometer to the cellular phone. The system enables the 
patient to regularly transmit blood glucose values and also to maintain contact through 
short text messages with health professionals as required.  
They were recommended to send blood glucose values recorded in the glucometer to the 
medical terminal once a week.  
An endocrinologist and a diabetes nurse educator evaluated patients´ data accessing into 
Emminens Conecta Plus Web Application (www.emminens.com) from any PC with 
Internet connection. Entering a personal password, they had access to blood glucose 
values sent by the patients, accompanied by their identification by initials, date and time 
of measurement. The application provides graphics with the trend of glycemia over time, 
charts of everyday and weekly glucose values, and the daily glycemic values of every 
patient. Health professionals can send text messages from their computer, which are 
received via Internet on the cellular phone of the patient. Through these messages, the 
professional makes recommendations on nutritional changes or adjustments in insulin 
doses. Patients can send text messages from their cellular phones to the medical terminal 
via Internet with questions as required, or answering to questions about their nutritional 
patterns or treatment. 
Statistical analysis 
Sample size was estimated for the hypothesis that the Telemedicine-based intervention will 
be no inferior to the traditional face-to-face usual treatment. A primary end point difference 
of the percentage of GDM patients achieving HbA1c values <5.8% more than 20% has been 
used. With 50 patients in each group, the study had 80% power to detect a 20% difference 
between groups at 5% significance. 
The statistical study was performed by using SPSS 15.0 program for windows. Descriptive 
data are expressed as median and Q1-Q3 or mean ± SDM. Non-parametric Mann-Whitney 
and Kreskas-Wallis test were carried out to detect significant differences between groups.  
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6.2 Results  
All women achieved HbA1c values <5.8% during pregnancy. The Telemedicine group 
transferred a median of 94 (34-127; Q1-Q3) values per patients of capillary blood glucose 
along a follow-up period of 9 (7-12) weeks. Five patients (10.2%) were not able to transmit 
any data. The professional posted a median of 5 (3-9) text messages per patient. The 
distribution according to the content of the messages is described in Table 1.  
 
Telemedicine Contacts Patients to Health Care Providers Health Care Providers to Patients 
Number of SMBG 
values 
93.12  + 70.77  
Number of SMS  1.63 + 3.87 6.39 + 4.84 
Contain of the SMS Answers about diet (60%) Positive reinforcement (40%) 
 Questions about diet (10%) Questions about diet (30%) 
 Questions about insulin (5%) Reminding transfer (15%) 
 Need of strips (10%) Need of insulin (6%) 
 Reporting technical problems 
(9%) 
Adjusting insulin dosage (4%) 
 Other issues (6%)  Other issues (5%) 
Data are Mean ±SDM or (%) 
SMBG denotes self-monitoring glucose values; SMS: short message service 
Table 1. Use of the Telemedicine system (Adapted from Pérez-Ferre N. et al, 2010) 
There was some kind of fault in the data transmission of 10 patients (20.4%), which forced 
the health professional to use the telephone to contact the patient. The major defects that 
were detected were caused by the use of the meter (modification by accident of the hour 
configuration that blocked the transmission of successive glucose values for security 
reasons, or inadequate use of the meter), pitfalls of the mobile terminal (not appropriate 
configuration of the mealtimes, not receiving text messages due to problems of the line), or 
technical problems with the web application. The patients had access to a telephone service 
to solve the fault in the transmission. 
The use of Telemedicine services compared with conventional monitoring reduced by 62% 
the number of non-scheduled face-to-face visits (1 ± 1.347 per patient in the control group to 
0.38 ± 0.684 per patients in the Telemedicine group; p <0.03).  
Seventeen patients (34. 7%) in the Telemedicine group required insulin versus 9 (18. 8%) in 
the control group. Differences in the week starting insulin treatment were not found (week 
26 (25-30) versus 28 (25-30), respectively; p=0.727), but a reduction of 82.7% in the number of 
non-scheduled visits in the Telemedicine group was observed (from 2. 89 ± 1.054 per patient 
to 0.50 ± 0.730 per patient, respectively; p<0.001). Data are displayed in Table 2.  
Differences in clinical and laboratory data during the follow-up were not found.  
In a similar way there were no differences in delivery and new born outcomes (Table 3). 
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 CONTROL Group TELEMEDICINE Group p 
Total Population (n) 48 49  
Face-to-face Visits 4.34 ± 1.73 3.98 ± 0.99 0.733 
Non-scheduled visits 1 ± 1.35 0.38 ± 0.68 0.033 
Insulin-treated 
patients 
9 (18.75%) 17(34.69%) 0.013 
Gestational weeks at 
insulinitation 
28.22 ± 3.80 
 
27.73 ± 3.13 
 
0.727 
Face-to-face visits 6.22 ± 1.48 4.25 ± 0.93 0.002 
Non-scheduled visits 2.89 ± 1.05 0.50 ± 0.73 0.0001 
Data are Mean ± SDM or n (%) 
Table 2. Visits at setting office. (Adapted from Pérez-Ferre N. et al, 2010) 
 
 CONTROL Group TELEMEDICINE Group p 
N 48 49  
Gestational Weeks at 
Delivery 
39.42 ± 1.42 39.12 ± 1.66 n.s. 
Mother Weight Gain (kg) 6.446 ± 4.988 5.820 ± 3.950 0.712 
Delivery Outcomes    
Eutocic 26 (54.2%) 20 (40.8%) 
Distocic 17 (35.4%) 27 (55.1%) 
 
0.068 
-Caesarean Section 12 (25%) 17 (34.7%) 
-Forceps 5 (10.4%) 10 (20.4%) 
 
0.427 
New born gender (M/F) 
22 (47.9%) / 
18 (37.5%) 
20 (40.8%) / 
26 (53.1%) 
0.240 
Birth weight (g) 
 
Male 
Female 
3370.6 ± 479.1 
 
3407.1 ± 492.2 
3346.9 ± 481.3 
3308.2 ± 488.8 
 
3214.5 ± 435.7 
3380.2 ± 522.9 
0.385 
Mother / New born 
Outcomes 
14 (29.2%) 11 (22.5%) 
Macrosomia 4 (8.3%) 3 (6.1%) 
Hypoglycemia 0 (0%) 1 (2%) 
Hypokaliemia 0 0 
Hypocalcemia 0 0 
Poliglobulia 0 0 
Loss of fetal wellbeing 5 (10.4%) 3 (6.1%) 
Umbillical cord patology 2 (4.2%) 1 (2.0%) 
Shoulders distocia 1 (2.1%) 0 (0%) 
Abrupto placentae 1 (2.1%) 0 (0%) 
High blood pressure-
proteinuria 
0 (0%) 2 (4.1%) 
0.115 
 
0.500 
 
 
 
 
 
 
Data are Mean ± SDM or n (%). 
Table 3. Delivery characteristics and new born data. (Adapted from Pérez-Ferre N. et al, 2010) 
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6.3 Conclusions from the study 
The present study shows that this Telemedicine system based on mobile technology and the 
Internet applied to the monitoring of gestational diabetes is feasible in clinical practice. A 
significant reduction in the number of visits was reported, mainly in the insulin-treated 
patients. Neither the evolution of pregnancy and delivery nor the newborn outcomes 
worsened. 
The reduction in the number of face-to-face visits  means a significant saving of time and an 
important improvement on patient convenience, especially in cases with difficulties in 
accessing the medical centre, either because of incompatibility with the working schedule, 
long distance to the medical centre or need for resting at certain times of pregnancy. Such a 
reduction became conspicuous in the subgroup of insulin-treated patients who require a 
higher number of contacts with the health professional to adjust the insulin dose. A trend 
toward an earlier insulinitation in the Telemedicine group was observed, but did not reach a 
significant difference in the week starting insulin treatment.  
The use of the Telemedicine system as an alternative to non-scheduled face-to face visits did 
not determine differences in the evolution of pregnancy (in terms of the parameters of 
metabolic control) or the final delivery parameters, nor in the newborn data, despite the 
higher proportion of patients using insulin in the Telemedicine group. 
The extent of the use of the Telemedicine system was very variable, highly depending on the 
cultural level and the skills in the management of the system. Patients who were unable to 
transmit any data had usually a lower educational level, difficulties with the language, or 
were not used to new technologies. At visit 1, all the patients assigned to the intervention 
group received information about the management of the system and were recommended to 
send the values of capillary blood glucose at least once a week. In contrast to other studies 
using similar Telemedicine-based services (Yoon et al., 2008), the patient does not require to 
access to a website in order to send and receive information, that is important in the group 
of patients with low resources and no access to a computer.  
The option to send text messages was generally underused by patients. The messages 
posted during the follow-up were mainly in response to questions from the professional. 
Most patients preferred face to face interview or the use of fixed telephony for questions 
they considered important, probably because they considered them more reliable media.  
The professional also used fixed telephony to contact the patient in certain cases, such as in 
the moment of start insulinitation or doubts about the implementation of capillary blood 
glucose determinations at appropriate time intervals. In some cases, an inappropriate setting 
of meal times in the mobile phone could lead to confusion in the interpretation of the pre-
and postprandial blood glucose values during the first week of monitoring, which led to 
consultation with the patient by fixed telephone.  
Professionals employed an average of 10 minutes per patient in the assessment of capillary 
blood glucose profiles sent to the terminal and the doctor weekly broadcast messages in 
response to the interpretation of the data. The face-to-face visit is estimated in about 15-20 
minutes. Therefore, the standard telematic visit saves time to the professional, in addition to 
significant savings in time for the patient, avoiding displacements to the medical centre and 
waiting to be attended. This savings in professional and patient time and working absences 
would result in a reduction of the overall costs of the process of patient care.  
When the Telemedicine system was offered, patients accepted the proposal in a positive 
way and showed their satisfaction at the end of the follow-up; however it was not 
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specifically measured in the present study, in contrast to others (Mair et al., 2000;  Long et 
al., 2005; Trief et al., 2008). They highly appreciated the possibility to communicate with the 
healthcare team as required. In next studies a specific quality of life questionnaire will be 
implemented (Bakken et al., 2006).  
We conclude that this Telemedicine system can be a useful tool in the treatment of diabetic 
patients, as long as a complement to conventional face-to-face monitoring, especially in 
cases requiring a tighter glycemic control, or with difficulties to access to the medical centre.  
7. Telemedicine application in the screening of diabetic retinopathy 
Diabetic retinopathy is the leading cause of blindness in people under 60 years old and a 
major cause in older people. It is a specific microvascular complication of diabetes, 
depending on the duration of diabetes and is associated with the degree of glycemic control. 
It is estimated that after 20 years from the onset of diabetes, over 60% of type 2 diabetic 
patients will have retinopathy. Hypertension is a risk factor for the development of macular 
edema and is associated with the presence of diabetic retinopathy. Glaucoma, cataracts and 
other changes may occur early in patients with diabetes and should also be evaluated. 
Retinal lesions with high risk of develop in blindness are often asymptomatic. Patients are 
not aware of these lesions if they are not examined periodically. When lesions are detected 
late in their evolution, the prognostic becomes worse: lesions can be irreversible at this 
moment.  The systematic screening of diabetic retinopathy is an effective tool for the 
reduction in the incidence of visual deficiencies and blindness. 
The transmission of digital images of the retina to specialized centres where they are 
examined and properly interpreted may increase the access to specialized care, improve the 
screening of diabetic retinopathy and make possible an early treatment.  
A screening protocol of diabetic retinopathy using Telemedicine has been developed in 
Hospital Clinico San Carlos from the year 2007 (Fernandez Romero et al., 2009). 
Diabetic patients are referred from their primary care physicians to be examined with a non-
midriatic digital camera in 2 specialized centres. The pictures from the retina are transmitted 
by Internet to Hospital Clinico San Carlos. Three endocrinologists evaluate the images once 
a week and select the patients that should be evaluated by the ophthalmologist. The report 
that can be read by primary care physicians from the area.  
Until January 31, 2010, 1473 patients were evaluated. Of them, only 15.3% were remitted to 
the ophthalmologist because of lesions of diabetic retinopathy. 13.5% of patients were 
remitted to the ophthalmologist because low quality of the images with non-midriatic 
camera. 56.7% of the patients are not referred to the specialist, and they are derived for a 
new examination with non-midriatic camera in one or 3 years, according to HbA1c level and 
other risk factors (hypertension, smoking habit, and microalbuminuria).  
The evaluation of diabetic retinopathy with non-midriatic camera, the interpretation by 
trained endocrinologists and the use of Telemedicine emerge as the best method for the 
screening of diabetic retinopathy. It allows optimizing sources and reducing the overload of 
diabetic patients at ophthalmology departments. This method also improves patient 
satisfaction. 
8. Future research in the field of telemedicine applied into diabetes 
Since January 2008, our group from Hospital Clinico San Carlos is participating in a 
European study promoted by the European Commission into the Seventh Framework 
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Fig. 1. Algorithm for the screening of diabetic retinopathy in Hospital Clinico San Carlos. 
(Adapted from Fernández Romero N. et al, 2009) 
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Programme. METABO project tries to create a global platform for the monitoring of all the 
parameters involved in diabetes. It not only monitors glucose values, but also food intake, 
level of exercise, energy expenditure, dose of insulin, other treatments, stress, environment... 
The control panel of METABO will be a graphical interface that will provide complete 
information about the patient, to be used by the patient and the health care team. It will 
display all the data well organized, with easy access for care providers anywhere with the 
frequency required by them. The final objective is to generate individual recommendations 
for the patient to improve his metabolic control and to make easier for the doctors the 
management of their patients. But also, data from a wide sample of patients may provide 
intelligent algorithms to relate the different parameters and predict behaviours. That is 
known as modelling in diabetes, a really interesting area on which many groups are 
working.  
The application of Telemedicine in the follow-up of other chronic complications of diabetes 
is also a very interesting area of research. 
- Telemedicine applied to the follow-up of diabetic neuropathy 
Diabetic neuropathy may lead to foot ulcers that need a very careful examination and an 
accurate and timely treatment to prevent a fatal evolution. The evaluation of foot ulcers 
through digital images that could be transmitted to experts (endocrinologists, podiatrists, 
vascular surgeons) would be a very useful system to improve the follow-up of lesions of 
diabetic neuropathy. An early detection of the lesion and the selection of the best 
management for each ulcer may improve the prognostic, even prevent a lower-extremity 
amputation. Images could be remitted from primary care physicians to specialised centres. 
Specialists will decide which patients must be referred to the hospital for advanced 
treatment (debridement of the ulcer, intravenous antibiotics). It will prevent the overload of 
patients in specialised centres. 
- Telemedicine applied to the follow-up of cardiovascular disease (ischemic heart disease) 
Diabetic patients who have suffered an ischemic heart event need an intensive follow-up 
after the event in order to control the glucose levels and the other important cardiovascular 
risk factors: blood pressure, lipids, weight and smoking habit. The tight control of all these 
factors can definitely prevent the occurrence of another heart event. Many of these patients 
are diagnosed of type 2 diabetes after their first heart event, and they have to start using 
insulin at that moment. They need an intensive education about diet, glucose monitoring, 
the use of insulin and/or glucose-lowering medications, the management of hypoglycemias, 
physical activity they can practise without risks… Other patients were diagnosed of diabetes 
before having the heart event but they must change their treatment after the event in order 
to improve their global control. The close monitorization of these patients by care providers 
will be crucial for the evolution of the disease. 
The application of telemedicine to the control of this group of patients would be very useful 
for the physicians and the patients. 
Data to monitor would be: patient’s profile (medical background, treatments, clinical and 
lab parameters), glucose monitoring, physical exercise, food intake and other events. In this 
group of patients, the cardiac function should be accurately defined in the medical 
background. It should include data from the electrocardiogram and the echocardiogram, 
systolic function, ventricular ejection fraction; last exercise test, data from the angiography 
(state of the coronary vessels, presence of stents or surgical coronary bypass). The 
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collaboration with Cardiologists would be recommendable for the inclusion and better 
evaluation of this information. 
There is also special interest in monitoring the cardiac response to exercise: heart rate, heart 
rate variability, blood pressure, modifications in ST in the electrocardiogram, adaptation to 
exercise after a cardiac event. 
- Other groups of patients with co-morbidities that could be interesting to monitor using 
Telemedicine would be: diabetic patient with renal disease, diabetic patients using steroids 
for a short period of time, diabetic patient with obesity. They all could beneficiate from a 
close monitoring from the health care team.  
9. Conclusions  
- Telemedicine can provide significant improvements in monitoring of diabetic patients, 
mainly in selected groups for their special care needs. 
- Telemedicine may help to achieve an intensive treatment of diabetes and to save time and 
cost in the care process. 
- A better monitoring of the diabetic patient may reduce the incidence of chronic 
complications of diabetes. This means an important reduction in morbi-mortality and the 
cost derived from the interventions.  
- The feedback from users is essential to increase the confidence of the professional and 
patient in the use of Telemedicine in clinical practice. 
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